M2A RINGLOC ACETABULAR LINER 28MM SIZE 25 STANDARD
Report
- Report Number
- 1825034-2011-00271
- Event Type
- Injury
- Date Received
- April 15, 2011
- Date of Event
- March 16, 2011
- Report Date
- March 22, 2011
- Manufacturer
- BIOMET ORTHOPEDICS
- Product Code
- KWA
- PMA / PMN Number
- K002379
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OH, US
- Reporter Occupation
- PHYSICIAN
Narratives
REVIEW OF DEVICE HISTORY RECORDS SHOW THAT LOT RELEASED WITH NO RECORDED ANOMALY OR DEVIATION. DATE IMPLANTED - UNKNOWN. EVALUATION OF THE RETURNED COMPONENT FOUND EVIDENCE OF DAMAGE FROM SURGICAL REMOVAL. THE ORIGINAL MACHINE LINES WERE PRESENT ON THE BACKSIDE OF THE POLYETHYLENE LINER EXCEPT FOR A NARROW BAND CLOSE TO THE APEX. THE LINER SHOWED CIRCULAR WITNESS MARKS FROM CONTACT WITH THE SCREW HOLES. THE ARTICULAR SURFACE OF THE COCR INSERT SHOWED EVIDENCE OF LIGHT SCRATCHING. THERE WAS NO EVIDENCE OF CHANGES IN SURFACE CONTOUR AT THE EDGES OF THE CONTACT AREA. THE OUTER RIM OF THE INSERT APPEARED TO SHOW EVIDENCE OF MINOR DEFORMATION IN ONE LOCATION. BASED UPON THE APPEARANCE OF THE COMPONENT, WEAR RATES DID NOT APPEAR TO BE EXCESSIVE. THE USER FACILITY WAS NOTIFIED OF THE EVENT ON (B)(6), 2011. TO DATE, A RESPONSE HAS NOT BEEN RECEIVED FROM THE USER FACILITY. IN THE EVENT THAT THE USER FACILITY SUBMITS A MEDWATCH REPORT, BIOMET WILL FORWARD A COPY TO THE FDA. (B)(4).
IT WAS REPORTED THAT PATIENT UNDERWENT TOTAL HIP ARTHROPLASTY ON UNKNOWN DATE. SUBSEQUENTLY, THE PATIENT WAS REVISED ON (B)(6), 2011 DUE TO PATIENT CONCERN OF METAL IONS. THE SURGEON NOTED DURING THE REVISION THAT THE COMPONENTS WERE WELL FIXED AND THERE WAS NO SIGN OF METAL DEBRIS. THE ACETABULAR LINER AND MODULAR HEAD WERE REMOVED AND REPLACED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | M2A RINGLOC ACETABULAR LINER 28MM SIZE 25 STANDARD | PROSTHESIS, HIP | KWA | BIOMET ORTHOPEDICS | N/A | 824980 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| R |